Prescription-friendly sunglasses designed for active lifestyles

Article

Viva International has released eight new prescription-ready sunglass styles for men and women in its Harley-Davidson Eyewear collection.

The men's collection offers five plastic models, one metal, and one metal front/plastic temple combination frame; all are classic rectangular shapes. Logo applications, including the brand's bar-and-shield logo and skull logo, are infused into the frame's temple design. The collection also includes one women's plastic model in a modified cat-eye shape detailed with a rivet-accented Harley-Davidson skull logo button plaque.

Available colors: black, brown, tortoise, and gunmetal. Available sizes: 55-18-135 to 59-17-130. Each frame comes with a branded hard case. Merchandising materials include a six-piece display unit and counter card featuring the brand's new print ad campaign.

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.